Cover Image

Interaction of myricetin, ampelopsin (dihydromyricetin), and their sulfate metabolites with serum albumin, cytochrome P450 (CYP2C9, 2C19, and 3A4) enzymes, and organic anion‐transporting polypeptides (OATP1B1 and OATP2B1)

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ágnes Dombi, Hana Kaci, Kateřina Valentová, Éva Bakos, Csilla Özvegy‐Laczka, Miklós Poór
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pharmacology Research & Perspectives
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Transport of aromatic amino acids l‐tryptophan, l‐tyrosine, and l‐phenylalanine by the organic anion transporting polypeptide (OATP) 3A1
by: Daniela B. Surrer, et al.
Published: (2024)

OATP2B1 Deficiency Ameliorates Irinotecan‐Induced Gastrointestinal Toxicity
by: Hanieh Taheri, et al.
Published: (2025)

Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay
by: Yi‐An Bi, et al.
Published: (2024)

Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor
by: Manthena V. S. Varma, et al.
Published: (2025)

A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions
by: Céline K. Stäuble, et al.
Published: (2024)

Pacific Blue Derivatives of Paclitaxel as Fluorescent Probes of OATP1B‐Type Transporters
by: Mahesh R. Nepal, et al.
Published: (2026)

Prevalence of OATP1B‐Mediated Drug–Drug Interactions in an Academic Medical Center
by: Mathilde Bories, et al.
Published: (2025)

Pregnenolone Sulfate Permeation at the Blood–Brain Barrier is Independent of OATP2B1—In Vivo and In Vitro Insights
by: Valerio Taggi, et al.
Published: (2025)

Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib
by: Panli Cardona, et al.
Published: (2024)

Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function
by: Kreetta Hämäläinen, et al.
Published: (2024)

Microdose Cocktail Study Reveals the Activity and Key Influencing Factors of OATP1B , P‐Gp, BCRP, and CYP3A in End‐Stage Renal Disease Patients
by: Weijie Kong, et al.
Published: (2025)

Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions
by: Leila Potzel, et al.
Published: (2026)

Molecular characterization of the cytochrome P450 enzyme CYP18A1 in Henosepilachna vigintioctopunctata
by: Yu‐Xing Zhang, et al.
Published: (2024)

In Vitro and Clinical Evaluations of UGT1A1‐, P‐gp‐, OATP1B1‐, and BCRP‐Mediated Drug–Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor
by: Olivier Schueller, et al.
Published: (2025)

Relationship of plasma 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease
by: Hiroyuki Ono, et al.
Published: (2024)

Hepatic OATP1B zonal distribution: Implications for rifampicin‐mediated drug–drug interactions explored within a PBPK framework
by: Mattie Hartauer, et al.
Published: (2024)

Population Pharmacokinetic Modeling of Glycochenodeoxycholic Acid 3‐O‐Sulfate ( GCDCA ‐S) as Endogenous Biomarker of OATP1B3 and OAT3 Transporters
by: Yuki Ujihira, et al.
Published: (2025)

Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target‐mediated drug disposition and OATP1B3‐mediated hepatic uptake in a physiologically based model
by: Toshiaki Tsuchitani, et al.
Published: (2024)

Frequency of Key Pharmacogenes CYP2C9 , CYP2C19 , CYP2D6 , and SLCO1B1 in the Yogyakarta Population: Implications for Precision Prescribing in Indonesia
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2026)

A novel cytochrome P450 gene, CYP12A2 , regulates reproduction of Mythimna separata by modulating 20E biosynthesis
by: Lingling Li, et al.
Published: (2026)

Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling
by: Sejung Hwang, et al.
Published: (2024)

Oil‐Assisted Thermal Processing ( OATP ) of In‐Shell Eggs: A Novel Approach Towards Functional Egg Powder Engineering
by: Emmanuel Cobbinah‐Sam, et al.
Published: (2026)

Food consumption, cytochrome P450 3A4 (CYP3A4) presystemic inhibitors, and bioavailability of saquinavir
by: P. Amariles
Published: (2007)

Repeated Intake of Grapefruit Juice Inhibits CYP2B6 , CYP2C9 , CYP2C19 , and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans
by: Laura Aurinsalo, et al.
Published: (2025)

The Arabidopsis cytochrome P450 enzyme CYP96A4 is involved in the wound‐induced biosynthesis of cuticular wax and cutin monomers
by: Haodong Huang, et al.
Published: (2024)

Effects of catechins, resveratrol, silymarin components and some of their conjugates on xanthine oxidase‐catalyzed xanthine and 6‐mercaptopurine oxidation
by: Tímea Bencsik, et al.
Published: (2024)

Induction of cytochrome P450 2C9 and P‐glycoprotein activity by antiseizure medications: A systematic review and network meta‐analysis
by: Hagar Cohen, et al.
Published: (2026)

Evaluation of cytochrome P450 (CYP) induction using RT‐qPCR in exosomes isolated from plasma samples: Method development and qualification
by: Shengjie Xu, et al.
Published: (2026)

Identification and functional analysis of CYP9A32, a cytochrome P450 gene associated with emamectin benzoate resistance in Spodoptera frugiperda
by: Jia‐Yu Lin, et al.
Published: (2025)

The effect of 2-methylisoborneol on cytochrome P450 expression in the channel catfish (Ictalurus punctatus) / Daniel Schlenk
by: Schlenk, Daniel
Published: (1994)

Identification of clerodane diterpene modifying cytochrome P450 (CYP728D26) in Salvia divinorum ‐ en route to psychotropic salvinorin A biosynthesis
by: Iris Ngo, et al.
Published: (2024)

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants
by: Jason D. Kim, et al.
Published: (2026)

Epigenetic mechanisms mediate cytochrome P450 1A1 expression and lung endothelial injury caused by MRSA in vitro and in vivo
by: Alison W. Ha, et al.
Published: (2024)

Pharmaceutical removal from wastewater by introducing cytochrome P450s into microalgae
by: Thamali Kariyawasam, et al.
Published: (2024)

Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population
by: Carolina Céspedes-Garro
Published: (2016)

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
by: Sylvia D. Klomp, et al.
Published: (2024)

CYP116B5‐SOX: An artificial peroxygenase for drug metabolites production and bioremediation
by: Daniele Giuriato, et al.
Published: (2024)

Correction to “Genetic Polymorphisms of ADH1C and CYP2E1 and Risk of Oral Squamous Cell Carcinoma”
Published: (2025)

CYP1B1 Mediates Cigarette Smoke–Induced Lipid Accumulation in Alveolar Type 2 Cells
by: Yin Zhu, et al.
Published: (2025)

Cryo‐ EM reveals an ensemble of cytochrome P450 reductase conformations in solution
by: Galina I. Lepesheva, et al.
Published: (2026)